New drug agent knocks out multiple enzymes in cancer pathway
Wednesday, March 25, 2009 - 14:14
in Health & Medicine
A team of 24 researchers from the U.S., Europe, Taiwan and Japan and led by University of Illinois scientists has engineered a new anti-cancer agent that is about 200 times more active in killing tumor cells than similar drugs used in recent clinical trials.